CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $140,054 | +1585.4% | 4,312 | +1313.8% | 0.01% | – |
| Q3 2023 | $8,310 | +22.5% | 305 | 0.0% | 0.00% | – |
| Q2 2023 | $6,786 | +32.7% | 305 | +29.2% | 0.00% | – |
| Q1 2023 | $5,112 | +411.2% | 236 | +661.3% | 0.00% | – |
| Q3 2022 | $1,000 | -99.9% | 31 | -69.9% | 0.00% | – |
| Q2 2018 | $1,619,000 | -4.4% | 103 | 0.0% | 0.00% | – |
| Q1 2018 | $1,694,000 | – | 103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,951,077 | $178,226,000 | 9.95% |
| Parallel Advisors, LLC | 3,769,455 | $96,649,000 | 4.45% |
| Novo Holdings A/S | 3,327,768 | $85,324,000 | 4.07% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $911,000 | 2.72% |
| Quantedge Capital Pte Ltd | 243,712 | $6,249,000 | 1.93% |
| S&T BANK/PA | 349,456 | $8,960,000 | 1.73% |
| Birchview Capital, LP | 50,000 | $1,282,000 | 0.90% |
| Bridge City Capital, LLC | 61,254 | $1,571,000 | 0.86% |
| FAS Wealth Partners, Inc. | 299,576 | $7,681,000 | 0.85% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $13,075,000 | 0.76% |